Gilead Sciences, Inc. has joined forces with Unite for HER (UFH) to introduce the Metastatic Breast Cancer Sustainer Program, a groundbreaking initiative aimed at providing free integrative care to Black, Hispanic, and underserved metastatic breast cancer patients across the United States. This program offers a range of services including acupuncture, professional counseling, personalized nutrition support, and fitness memberships, all at no cost to the patient.
Sue Weldon, Founder and CEO of Unite for HER, emphasized the program's impact, stating it has become a crucial support system for members, particularly those from marginalized communities. The initiative not only aims to improve the quality of life for these patients but also to ensure they remain on their treatment paths, addressing both physical and emotional needs.
Carmen Villar, Senior Vice President of Global Giving, Advocacy, and Responsibility at Gilead Sciences, highlighted the company's commitment to addressing the unique challenges faced by the metastatic breast cancer community. This partnership underscores Gilead's dedication to creating meaningful change and supporting equitable access to care.
Since its inception in October 2023, the program has already made a significant difference in the lives of over 2,823 patients. With Gilead Sciences' funding, the program is expanding its focus to specifically aid Black, Hispanic, and underserved populations, furthering its mission of providing dignity, equity, and whole-person care.
For more information on the Metastatic Breast Cancer Sustainer Program and other free services offered by Unite for HER, visit https://www.uniteforher.org.
